Companies: 10,795·Total market cap: $144.5T
DBV Technologies S.A.

DBV Technologies S.A.

DBVTNASDAQHealthcare● Active
$16.59
$-0.99(-5.63%)
Market Cap$396861650
P/E Ratio
52W High$26.185
52W Low$8.3
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

DBV Technologies S.A. (DBVT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001613780 · DBVT · NASDAQ · as of Jun 8, 2026

Filing snapshot

566
Total Filings
8-K
Latest Form
2026-06-05
Most Recent
2014
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001613780 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001193125-26-197148
Primary Document
d120451d10ka.htm
Source: data.sec.gov · CIK 0001613780 · Accession 0001193125-26-197148

Latest Key Filings

6-KQuarterly Report
6-K
2020-12-28
8-KCurrent Report
8-K
2026-06-05Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-05
View
S-8Employee Stock Plan Registration
S-8
2026-06-04
View
8-KCurrent Report
8-K
2026-06-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-12
View
ARSARS
ARS
2026-05-11
View
DEF 14AProxy Statement
DEF 14A
2026-05-11
View
8-KCurrent Report
8-K
2026-05-05
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-05
View
S-8Employee Stock Plan Registration
S-8
2026-05-04
View
PRE 14APRE 14A
PRE 14A
2026-05-01
View
8-KCurrent Report
8-K
2026-04-30
View
10-QQuarterly Report
10-Q
2026-04-30
View
Showing 1–15 of 528 filingsForm 4 / 144 hidden· 566 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001613780  |  Exchange: NASDAQ · Healthcare

DBV Technologies S.A. (NASDAQ: DBVT) has submitted 566 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001613780, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is DBV Technologies S.A.'s most comprehensive regulatory disclosure. The most recent DBV Technologies S.A. 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical DBVT 10-K annual reports are available from 2014 through 2026.

Investors researching DBV Technologies S.A. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

DBVT SEC Filings · 8 questions

DBV Technologies S.A. (DBVT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 566 filings and access original documents at no cost. DBV Technologies S.A.'s CIK is 0001613780.

DBVT SEC filingsDBV Technologies S.A. SEC documentsfind DBVT 10-K